Drug & supplement interaction

Pata De Vaca + Ranibizumab

Ranibizumab brand names: Lucentis, Susvimo.

No Known Interaction

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated June 2026 · Pair last verified Sep 20, 2026

The bottom line No known interaction

We found no known interaction between Pata De Vaca and Ranibizumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share

Facebook Post Reddit Email

On this page

Interaction report

Pata De Vaca and Ranibizumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Ranibizumab and Pata De Vaca in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Pata De Vaca safety at a glance

Pata De Vaca overall Use caution Limited human safety data, so use carefully and under professional guidance.

Pregnancy Avoid Not enough safety information; avoid during pregnancy.

Breastfeeding Avoid Not enough safety information; avoid while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Ranibizumab and Pata De Vaca? Ask Dr. Brian Staiger, PharmD, BCPS directly ›

Keep it in perspective

Pata De Vaca Does Interact With Other Medications

Pata De Vaca has 86 moderate known drug interactions in our database — Ranibizumab isn’t one of them. If you take anything else, check it against the full list below.

Moderate 86 No known interaction 2,744 (incl. Ranibizumab)

Taking anything else?

Check Another of Your Medications Against Pata De Vaca

Covers the 2,830 medications we’ve checked against Pata De Vaca. Pick one to open its full report.

What to actually watch for

What Ranibizumab’s Own FDA Label Lists

This is not an interaction — none of it involves Pata De Vaca. These are the most notable effects listed in the ADVERSE REACTIONS section of Ranibizumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 5 of them are worth acting on rather than waiting out — marked below.

An irregular heartbeat Worth acting on
Kidney problems Worth acting on
Bleeding or bruising Worth acting on mentioned in 4.0% of FDA reports for Ranibizumab
Anemia Worth acting on
A higher chance of infection Worth acting on
Blurred vision mentioned in 21.1% of FDA reports for Ranibizumab
Eye irritation or redness
Dry eyes
Heartburn
Numbness or tingling

Showing the 10 most notable of 16 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Ranibizumab. Read the label on DailyMed › Where a percentage is shown, it is the share of 26,416 voluntary FDA FAERS reports for Ranibizumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Pata De Vaca’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Pata De Vaca side to compare — that is a limit of the record, not a statement that Pata De Vaca has no side effects.

Overlapping uses

What Ranibizumab Is Prescribed For, and What Pata De Vaca Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Ranibizumab is a prescription medicine with approved uses on its FDA label. Pata De Vaca is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Ranibizumab is prescribed for: Ranibizumab injection treats serious eye conditions that involve abnormal blood vessel growth or fluid leakage in the eye. It is used for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR). Susvimo (ranibizumab injection) is specifically approved for patients with wet AMD, DME, or DR who have already responded to at least two intravitreal (into-the-eye) injections of a VEGF inhibitor medication. Lucentis (ranibizumab injection) is used for wet AMD, DME, diabetic retinopathy, macular edema following retinal vein occlusion, and myopic choroidal neovascularization (abnormal blood vessel growth related to severe nearsightedness).

Pata De Vaca has been studied for:

Diabetes studied, not established Pata De Vaca has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows
Pata De Vaca for diabetes
Preliminary clinical research in patients with and without type 2 diabetes shows that drinking an herbal tea containing pata de vaca 3 grams daily for 8 weeks does not improve fasting plasma glucose, insulin, or glycated hemoglobin levels compared to placebo.
3 sources cited

27471. Russo EM, Reichelt AA, De Sa JR, et al. Clinical trial of Myrcia uniflora and Bauhinia forficata leaf extracts in normal and diabetic patients. Braz J Med Biol Res 1990;23(1):11-20.

100154. Córdova Mariángel P, Avello Lorca M, Morales Leon F, et al. Effects of Bauhinia forficata link tea on lipid profile in diabetic patients. J Med Food. 2019;22(3):321-323.

112066. Tonelli CA, de Oliveira SQ, Silva Vieira AAD, et al. Clinical efficacy of capsules containing standardized extract of Bauhinia forficata Link (pata-de-vaca) as adjuvant treatment in type 2 diabetes patients: A randomized, double blind clinical trial. J Et PubMed

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Ranibizumab on your own; if you are taking Pata De Vaca for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

One more smart check

Taking Pata De Vaca as Part of a Dietary Supplement Product? Check It for Interactions

We hold 7 real supplement products containing Pata De Vaca, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Pata De Vaca. Even though Pata De Vaca itself has no known interaction with Ranibizumab, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Pata De Vaca and Ranibizumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Pata De Vaca

Steady interest

#1,100 of 1,452 supplements looked up here in the last 7 days

29 days ago today

Medication Ranibizumab

Steady interest

#2,700 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?

Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Pata De Vaca reference on this page ↓
Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Pata De Vaca and Ranibizumab records this page draws on were last updated June 22, 2026.
What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.

Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD, BCPS.

Supplement

About Pata De Vaca

What is Pata De Vaca?

Blood sugar support
Diabetes (traditional use)
Diuretic
Kidney and urinary health
General tonic

Pata de Vaca is a South American plant whose leaves are traditionally brewed as a tea to help support blood sugar, earning it the nickname 'vegetable insulin.' Human evidence is very limited, so it should not replace prescribed diabetes treatment. Talk to your pharmacist or doctor before using it, especially if you take blood-sugar medications.

Bauhinia forficata · Fabaceae · Leaves · Tea (infusion), capsules, dried leaf, liquid extract

An interaction check asks whether these two react with each other — it does not ask whether Pata De Vaca is a good idea for someone in your situation. Here is what our Pata De Vaca record says about it on its own.

Pata De Vaca: dosing

There is no established standardized dose for Pata de Vaca. Traditional use is mostly as a leaf tea, but the strength of teas and supplements varies widely between products.If you choose to use it, follow the directions on the product label and start low.

From our Pata De Vaca monograph — the full record covers uses, side effects and every documented interaction.

Read the full Pata De Vaca monograph & all interactions

Medication

About Ranibizumab Injection

What Is Ranibizumab Injection Used For?

Brand names: Lucentis, Susvimo

Ranibizumab injection treats serious eye conditions that involve abnormal blood vessel growth or fluid leakage in the eye. It is used for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR).

Susvimo (ranibizumab injection) is specifically approved for patients with wet AMD, DME, or DR who have already responded to at least two intravitreal (into-the-eye) injections of a VEGF inhibitor medication. Lucentis (ranibizumab injection) is used for wet AMD, DME, diabetic retinopathy, macular edema following retinal vein occlusion, and myopic choroidal neovascularization (abnormal blood vessel growth related to severe nearsightedness).

Most-Reported Side Effects for Ranibizumab

From FAERS, the FDA’s public side-effect reporting system (26,591 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Visual acuity reduced 2,907 reports

Visual impairment 1,654 reports

Cerebrovascular accident 1,238 reports

Blindness 1,051 reports

Eye haemorrhage 1,047 reports

See full Ranibizumab Injection drug information

Keep checking

Other Drugs & Pata De Vaca

Browse every other medication we’ve checked against Pata De Vaca — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major

86Moderate

0Minor

2,743No known interaction

86 Moderate 2,743 No interaction

Moderate

86 interactions

Showing 60 of 86 moderate interactions — see all 86 on the Pata De Vaca page.

No interaction 2,743 drugs checked — show the list

We also checked Pata De Vaca against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,743 medications checked with no known interaction — see the full Pata De Vaca list.

See the full Pata De Vaca interactions page

See every supplement checked against Ranibizumab, ranked by severity

Evidence & sources

Pata De Vaca References

The 10 references that drive our Pata De Vaca monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Russo EM, Reichelt AA, De Sa JR, et al. Clinical trial of Myrcia uniflora and Bauhinia forficata leaf extracts in normal and diabetic patients. Braz J Med Biol Res 1990;23(1):11-20.
da Cunha AM, Menon S, Menon R, et al. Hypoglycemic activity of dried extracts of Bauhinia forficata Link. Phytomedicine 2010;17(1):37-41. PubMed
Lino Cde S, Diogenes JP, Pereira BA, et al. Antidiabetic activity of Bauhinia forficata extracts in alloxan-diabetic rats. Biol Pharm Bull 2004;27(1):125-7. PubMed
Silva FR, Szpoganicz B, Pizzolatti MG, et al. Acute effect of Bauhinia forficata on serum glucose levels in normal and alloxan-induced diabetic rats. J Ethnopharmacol 2002;83(1-2):33-7. PubMed
Pepato MT, Keller EH, Baviera AM, et al. Anti-diabetic activity of Bauhinia forficata decoction in streptozotocin-diabetic rats. J Ethnopharmacol 2002;81(2):191-7. PubMed
Jorge AP, Horst H, de Sousa E, et al. Insulinomimetic effects of kaempferitrin on glycaemia and on 14C-glucose uptake in rat soleus muscle. Chem Biol Interact 2004;149(2-3):89-96. PubMed
de Sousa E, Zanatta L, Seifriz I, et al. Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves. J Nat Prod 2004;67(5):829-32.
Vasconcelos F, Sampaio SV, Garofalo MA, et al. Insulin-like effects of Bauhinia forficata aqueous extract upon Tityus serrulatus scorpion envenoming. J Ethnopharmacol 2004;95(2-3):385-92. PubMed
Córdova Mariángel P, Avello Lorca M, Morales Leon F, et al. Effects of Bauhinia forficata link tea on lipid profile in diabetic patients. J Med Food. 2019;22(3):321-323.
Tonelli CA, de Oliveira SQ, Silva Vieira AAD, et al. Clinical efficacy of capsules containing standardized extract of Bauhinia forficata Link (pata-de-vaca) as adjuvant treatment in type 2 diabetes patients: A randomized, double blind clinical trial. J Et PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Pata De Vaca and Ranibizumab Together: Common Questions

Is it safe to take Pata De Vaca with Ranibizumab?

We do not list a known interaction between Pata De Vaca and Ranibizumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.

Are Pata De Vaca and Ranibizumab used for the same thing?

They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Pata De Vaca in each. That is a conversation for your prescriber, especially if Ranibizumab is being adjusted to a target.

Does Pata De Vaca interact with any other medications?

Yes. Pata De Vaca has 86 documented drug interactions in our database — Ranibizumab is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Pata De Vaca monograph Uses, safety profile, and every drug interaction in one place Ranibizumab Injection drug information The full plain-English guide to this medication Ranibizumab supplement interactions Every supplement checked against Ranibizumab, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 10 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Ranibizumab and Pata De Vaca?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.